Hannes Snellman Counsel to Recipharm AB (publ) in the Divestment of the Rights to its ThyroSafe Product

15 June 2018

Hannes Snellman acted as counsel to Recipharm AB (publ) in the divestment of the rights to its potassium iodide product ThyroSafe, except for the US territory, to SERB SA.

Follow us on Social Media

General Terms and Conditions
Scam & Fraud Notice
Privacy Notice
Cookie Policy

Hannes Snellman's website is intended for
information purposes only. It should not be
relied upon as legal advice nor should it be
used as a basis for any action or decision.